A randomised, double blind, placebo-controlled trial of a two-week course of dexamethasone for adult patients with a symptomatic Chronic Subdural Haematoma (Dex-CSDH trial)

Hutchinson, P J, Edlmann, E, Hanrahan, J G, Bulters, D, Zolnourian, A, Holton, P, Suttner, N, Agyemang, K, Thomson, S, Anderson, I A, Al-Tamimi, Y, Henderson, D, Whitfield, P, Gherle, M, Brennan, P M, Allison, A, Thelin, E P, Tarantino, S, Pantaleo, B, Caldwell, K, Davis-Wilkie, C, Mee, H, Warburton, E A, Barton, G, Chari, A, Marcus, H J, Pyne, S, King, A T, Belli, A, Myint, P K, Wilkinson, I, Santarius, T, Turner, C, Bond, S, Kolias, A G & British Neurosurgical Trainee Research Collaborative and Dex-CSDH Trial Collaborators 2024, 'A randomised, double blind, placebo-controlled trial of a two-week course of dexamethasone for adult patients with a symptomatic Chronic Subdural Haematoma (Dex-CSDH trial)', Health Technology Assessment, vol. 28, no. 12, pp. 1-122. https://doi.org/10.3310/XWZN4832